PREPL, a Prolyl Endopeptidase-Like Enzyme by Name Only? Lessons from Patients

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|3|355-360

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.3, 2011-05, pp. : 355-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Prolyl Endopeptidase in Intracellular Transport and Protein Secretion

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 3, 2011-05 ,pp. : 327-332

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats

By Shishido Y.   Furushiro M.   Tanabe S.   Shibata S.   Hashimoto S.   Yokokura T.  

European Journal of Pharmacology, Vol. 372, Iss. 2, 1999-05 ,pp. : 135-142

Elsevier

Access to resources Recommend Favorite

Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion

By Shinoda M.   Matsuo A.   Toide K.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin

By Pham I.   Gonzalez W.   Doucet J.   Fournie-Zaluski M.-C.   Roques B.P.   Michel J.-B.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 267-276

Elsevier

Access to resources Recommend Favorite

Dual ACE and Neutral Endopeptidase Inhibitors: Novel Therapy for Patients with Cardiovascular Disorders

By Tabrizchi R.  

Drugs, Vol. 63, Iss. 20, 2003-01 ,pp. : 2185-2202

Adis International

Access to resources Recommend Favorite